HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model.

AbstractOBJECTIVE:
To estimate the impact of late ART initiation on HIV transmission among men who have sex with men (MSM) in Mexico.
METHODS:
An HIV transmission model was built to estimate the number of infections transmitted by HIV-infected men who have sex with men (MSM-HIV+) MSM-HIV+ in the short and long term. Sexual risk behavior data were estimated from a nationwide study of MSM. CD4+ counts at ART initiation from a representative national cohort were used to estimate time since infection. Number of MSM-HIV+ on treatment and suppressed were estimated from surveillance and government reports. Status quo scenario (SQ), and scenarios of early ART initiation and increased HIV testing were modeled.
RESULTS:
We estimated 14239 new HIV infections per year from MSM-HIV+ in Mexico. In SQ, MSM take an average 7.4 years since infection to initiate treatment with a median CD4+ count of 148 cells/mm3(25th-75th percentiles 52-266). In SQ, 68% of MSM-HIV+ are not aware of their HIV status and transmit 78% of new infections. Increasing the CD4+ count at ART initiation to 350 cells/mm3 shortened the time since infection to 2.8 years. Increasing HIV testing to cover 80% of undiagnosed MSM resulted in a reduction of 70% in new infections in 20 years. Initiating ART at 500 cells/mm3 and increasing HIV testing the reduction would be of 75% in 20 years.
CONCLUSION:
A substantial number of new HIV infections in Mexico are transmitted by undiagnosed and untreated MSM-HIV+. An aggressive increase in HIV testing coverage and initiating ART at a CD4 count of 500 cells/mm3 in this population would significantly benefit individuals and decrease the number of new HIV infections in Mexico.
AuthorsYanink Caro-Vega, Carlos del Rio, Viviane Dias Lima, Malaquias Lopez-Cervantes, Brenda Crabtree-Ramirez, Sergio Bautista-Arredondo, M Arantxa Colchero, Juan Sierra-Madero
JournalPloS one (PLoS One) Vol. 10 Issue 8 Pg. e0136534 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26302044 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Female
  • HIV (pathogenicity)
  • HIV Infections (epidemiology, therapy, transmission)
  • Homosexuality, Male
  • Humans
  • Male
  • Mass Screening
  • Mexico
  • Models, Theoretical
  • Risk-Taking
  • Sexual Behavior (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: